Check, J H, Chan, S · Clinical and experimental obstetrics & gynecology · 2014
This study describes two patients with ME/CFS who also had long-standing skin conditions (eczema and keratosis pilaris) that improved significantly when treated with dextroamphetamine, a stimulant medication. The authors suggest these skin problems may be related to an underactive nervous system that is also involved in ME/CFS, and that stimulant treatment may help both conditions.
This study suggests a potential mechanistic link between sympathetic nervous system dysfunction, skin inflammation, and ME/CFS symptoms. If validated, identifying and treating autonomic nervous system dysfunction could address multiple co-occurring symptoms in ME/CFS patients, improving quality of life across multiple domains.
This case report cannot establish causation or generalizability—two clinical observations do not prove that sympathomimetic therapy is effective for ME/CFS-related dermatologic conditions in broader populations. The improvement in skin symptoms may be coincidental, reflect placebo response, or result from unmeasured confounding factors. No control group or blinded assessment means bias and subjective reporting cannot be excluded.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.